US pricing: parity between biologics and small moleculesRachel Ougier SimoninMar 7, 20241 min readhttps://www.biospace.com/article/stakeholders-hope-bill-will-create-ira-drug-negotiation-parity-between-biologics-and-small-molecules-/
LISTEN & LEARN: BIOPHARMACEUTICAL PRODUCT FORECASTINGPlease find enclosed the slides created by Robert F. Siegmund for our Listen & Learn on product forecasting.
Listen & Learn: ForesightPlease find enclosed the Foresight L&L presentation, brought to our community by our HCD member Antonis Sarlikiotis.
Commentaires